Focus particularly on protein intake, as this is the most commonly deficient macronutrient during Retatrutide treatment
The platform provides ongoing care, so people can message a Ro doctor anytime if they have questions about their treatment
While these patient reports are anecdotal and more research is needed, they suggest that even modest doses could potentially influence how some people feel and function in their daily lives
Key findings: Prescribing trends Using a subset of real-world electronic health record (EHR) data from Truveta, Truveta Research identified people who were prescribed a GLP-1 RA between January 01, 2018 and September 30, 2024
Treatment not only suppressed the HFD-driven overexpression of lipogenic genes (e.g., Fasn , -22%
Additionally, a study published in The Lancet in February 2026 found that taking Foundayo, Eli Lillys GLP-1 pill that was approved by the FDA in April, resulted in greater weight loss and blood sugar level reductions compared to Rybelsus, another oral GLP-1 manufactured by Novo Nordisk
